Volume 63, Issue 5, Pages (May 2003)

Slides:



Advertisements
Similar presentations
Volume 62, Pages S12-S22 (December 2002)
Advertisements

Volume 65, Issue 1, Pages (January 2004)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 63, Issue 6, Pages (June 2003)
Volume 64, Issue 6, Pages (December 2003)
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 56, Issue 3, Pages (September 1999)
Volume 54, Issue 1, Pages (July 1998)
Volume 81, Issue 9, Pages (May 2012)
Volume 58, Issue 4, Pages (October 2000)
Volume 65, Issue 1, Pages (January 2004)
Volume 81, Issue 9, Pages (May 2012)
Volume 66, Issue 6, Pages (December 2004)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 58, Issue 6, Pages (December 2000)
Volume 75, Issue 10, Pages (May 2009)
Volume 66, Issue 5, Pages (November 2004)
Volume 63, Issue 6, Pages (June 2003)
Volume 54, Issue 3, Pages (September 1998)
Volume 69, Issue 1, Pages (January 2006)
Volume 63, Issue 2, Pages (February 2003)
Expression of platelet-derived growth factor and its receptors in the developing and adult mouse kidney  Ronald A. Seifert, Charles E. Alpers, Daniel.
Volume 59, Issue 5, Pages (May 2001)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 54, Issue 5, Pages (November 1998)
Volume 57, Issue 2, Pages (October 2000)
Volume 63, Issue 2, Pages (February 2003)
Prenatal programming of adult hypertension in the rat
Volume 57, Issue 3, Pages (March 2000)
Volume 57, Issue 5, Pages (May 2000)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 64, Issue 4, Pages (October 2003)
Volume 63, Issue 2, Pages (February 2003)
Volume 70, Issue 10, Pages (November 2006)
Volume 57, Issue 1, Pages (January 2000)
Volume 53, Issue 5, Pages (May 1998)
Volume 62, Issue 2, Pages (August 2002)
Volume 61, Issue 6, Pages (June 2002)
Lymphatic vessels develop during tubulointerstitial fibrosis
Volume 60, Issue 6, Pages (December 2001)
Volume 63, Issue 6, Pages (June 2003)
Volume 57, Issue 3, Pages (March 2000)
Volume 64, Pages S64-S70 (October 2003)
Volume 57, Issue 1, Pages (January 2000)
Volume 73, Issue 12, Pages (June 2008)
Volume 63, Issue 4, Pages (April 2003)
Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney  Yee-Yung Ng, Chun-Cheng Hou, Wansheng.
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 59, Issue 3, Pages (March 2001)
Volume 65, Issue 2, Pages (February 2004)
Macrophages and hypoxia in human chronic kidney disease
Volume 58, Issue 6, Pages (December 2000)
Volume 67, Issue 2, Pages (February 2005)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 62, Pages S12-S22 (December 2002)
Volume 54, Issue 4, Pages (October 1998)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 56, Issue 2, Pages (August 1999)
Volume 59, Issue 5, Pages (May 2001)
Volume 68, Issue 5, Pages (November 2005)
Volume 69, Issue 11, Pages (June 2006)
Volume 58, Issue 3, Pages (September 2000)
Aldosterone in the development and progression of renal injury
Volume 58, Issue 4, Pages (October 2000)
Volume 59, Issue 5, Pages (May 2001)
Effects of cyclosporine in osteopontin null mice1
Effect of prenatal dexamethasone on rat renal development
The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?  Richard E. Gilbert, Mark E. Cooper  Kidney.
J. Ma, A. Weisberg, J.P. Griffin, D.E. Vaughan, A.B. Fogo, N.J. Brown 
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Volume 63, Issue 5, Pages 1791-1800 (May 2003) Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats  Eileen R. Blasi, Ricardo Rocha, Amy E. Rudolph, Eric A.G. Blomme, Melissa L. Polly, Ellen G. McMahon  Kidney International  Volume 63, Issue 5, Pages 1791-1800 (May 2003) DOI: 10.1046/j.1523-1755.2003.00929.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Systolic blood pressure measured over time using radiotelemetry in control, aldosterone/1% NaCl, and aldosterone/1% NaCl + eplerenone rats. All rats were uninephrectomized and placed on 1% NaCl for 28 days and received subcutaneous minipumps containing either vehicle or aldosterone (0.75 μg/hour). Eplerenone was administered in the diet at a dose of 100 mg/kg/day. Values represent mean ± SEM. *P < 0.05 vs. control; +P < 0.05 vs. aldosterone/1% NaCl. Kidney International 2003 63, 1791-1800DOI: (10.1046/j.1523-1755.2003.00929.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Representative photomicrographs from kidneys of control (left column), aldosterone/1% NaCl (middle column), and aldosterone/1%NaCl + eplerenone (right column) rats after 28 days of treatment. Periodic acid-Schiff (PAS) staining. Kidneys from control rats appeared normal (A), while kidneys from aldosterone/1% NaCl animals (B) displayed marked vascular and glomerular damage characterized by arterial fibrinoid necrosis with segmental myointimal proliferation and adventitial fibrosis (black arrow), glomerular mesangiolysis with fibrinoid necrosis and thrombosis (arrowhead), leukocyte infiltration, protein casts, and tubular dilation (white arrows). With eplerenone treatment (C), injuries were markedly reduced (A to C, ×100). ED1 and CD3 immunostaining of control, aldosterone/1% NaCl and aldosterone/1% NaCl + eplerenone rats. In contrast to those of control animals (D and G), kidney sections of aldosterone/1% NaCl rats contained frequent ED1-positive macrophages (E) within the interstitium (arrow) and blood vessels (arrowhead), as well as CD3-positive T cells (H; arrow). ED1 and CD3 immunohistochemistry demonstrated a lower number of infiltrating macrophages and T cells in the eplerenone-treated rats (F and I) (D to I, ×100). Vimentin immunohistochemistry. Vimentin-positive tubular epithelial cells were rarely found in control (J) and aldosterone/1% NaCl + eplerenone (L) rats in contrast to aldosterone/1% NaCl rats, where many tubules were vimentin positive (K; arrows) (J to L, ×50). Type III collagen in situ hybridization was used to demonstrate the early fibrosis in aldosterone/1% NaCl rats (N; arrows), while type III collagen mRNAs were rarely detected in both control (M) and aldosterone/1% NaCl + eplerenone (O) rats (M to O, ×50, dark-field microscopy). Kidney International 2003 63, 1791-1800DOI: (10.1046/j.1523-1755.2003.00929.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Representative photomicrographs of osteopontin (OPN) immunohistochemistry and in situ hybridization. OPN was detected in the medulla (loop of Henle, distal nephrons) of control rats but only rarely in the cortex. Following aldosterone/1% NaCl treatment (A and B), OPN expression was markedly up-regulated in the medulla and in both proximal and distal cortical tubules, with the most robust up-regulation affecting the damaged and regenerative tubules (arrows). Scattered myointimal cells of arteries (arrowheads) and infiltrating macrophages also expressed OPN. Aldosterone/1% NaCl rats treated with eplerenone exhibited only limited OPN staining (C and D). (A and C, ×200; B and D, ×200, bright-field microscopy). Kidney International 2003 63, 1791-1800DOI: (10.1046/j.1523-1755.2003.00929.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Representative photomicrographs of monochemoattractant 1 (MCP-1) in situ hybridization in the kidneys of aldosterone/1% NaCl (A and B) and aldosterone/1% NaCl + eplerenone (C and D) rats. MCP-1 mRNA could rarely be detected in the kidneys of control and eplerenone-treated rats. In contrast, in aldosterone/1% NaCl animals, MCP-1 mRNA was detected multifocally in damaged and regenerative tubules (arrows), as well as in interstitial macrophages, scattered vascular smooth muscle cells, scattered arteriolar endothelial cells, and glomerular endothelial and epithelial cells. (A and C, × 200, bright-field microscopy; B and D, ×200, dark-field microscopy). Kidney International 2003 63, 1791-1800DOI: (10.1046/j.1523-1755.2003.00929.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Renal cortex mRNA levels of proinflammatory genes osteopontin (OPN) (A), monocyte chemoattractant protein-1 (MCP-1) (B), interleukin-1β (IL-1β) (C) and interleukin-6 (IL-6) (D) from control, aldosterone/1% NaCl (Aldo) and aldosterone/1% NaCl + eplerenone (Aldo + epl) rats after 28 days of treatment. Eplerenone was administered in the diet at a dose of 100 mg/kg/day. Values represent means ± SEM. *P < 0.05 vs. control; +P < 0.05 vs. aldosterone/1% NaCl. Kidney International 2003 63, 1791-1800DOI: (10.1046/j.1523-1755.2003.00929.x) Copyright © 2003 International Society of Nephrology Terms and Conditions